Table 5.
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|
Odds ratio | Confidential interval (95%) | P | Odds ratio | Confidential interval (95%) | P | |
Age | 0.96 | 0.84–1.11 | 0.62 | Excluded | ||
Preoperative PSA | 1.19 | 1.07–1.24 | 0.002 | 1.18 | 1.04–1.34 | 0.011 |
BMI | 1.1 | 0.96–1.26 | 0.17 | Excluded | ||
Race | 0.23 | Excluded | ||||
White | Ref | Ref | ||||
Asian | 6.91 | 0.77–61.91 | ||||
African American | 1.32 | 0.16–10.77 | ||||
Free testosterone | ||||||
Low vs. normal | 6.88 | 1.61–29.48 | 0.009 | 9.45 | 1.52–58.69 | 0.016 |
Total testosterone | ||||||
Low vs. normal | 8.76 | 1.97–38.98 | 0.004 | 12.35 | 2.1–72.49 | 0.005 |
No. of positive cores | 1.46 | 1.19–1.78 | <0.01 | 1.27 | 0.99–1.62 | 0.053 |
Clinical stage | Excluded | |||||
T1 | Ref | Ref | ||||
T2 | 1.05 | 0.13–8.74 | 0.96 |
Biopsy Gleason scores presented sparseness in the data and were not included in the logistic regression model.
BMI, body mass index; PSA, prostate-specific antigen; Ref, reference.